These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
343 related articles for article (PubMed ID: 9462678)
1. Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. van Dam FS; Schagen SB; Muller MJ; Boogerd W; vd Wall E; Droogleever Fortuyn ME; Rodenhuis S J Natl Cancer Inst; 1998 Feb; 90(3):210-8. PubMed ID: 9462678 [TBL] [Abstract][Full Text] [Related]
2. Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Schagen SB; van Dam FS; Muller MJ; Boogerd W; Lindeboom J; Bruning PF Cancer; 1999 Feb; 85(3):640-50. PubMed ID: 10091737 [TBL] [Abstract][Full Text] [Related]
3. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. Ahles TA; Saykin AJ; Furstenberg CT; Cole B; Mott LA; Skalla K; Whedon MB; Bivens S; Mitchell T; Greenberg ER; Silberfarb PM J Clin Oncol; 2002 Jan; 20(2):485-93. PubMed ID: 11786578 [TBL] [Abstract][Full Text] [Related]
4. Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function. Schagen SB; Hamburger HL; Muller MJ; Boogerd W; van Dam FS J Neurooncol; 2001 Jan; 51(2):159-65. PubMed ID: 11386413 [TBL] [Abstract][Full Text] [Related]
5. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy. Mehnert A; Scherwath A; Schirmer L; Schleimer B; Petersen C; Schulz-Kindermann F; Zander AR; Koch U Patient Educ Couns; 2007 Apr; 66(1):108-18. PubMed ID: 17320337 [TBL] [Abstract][Full Text] [Related]
6. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Wefel JS; Lenzi R; Theriault RL; Davis RN; Meyers CA Cancer; 2004 Jun; 100(11):2292-9. PubMed ID: 15160331 [TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life in early breast cancer. Groenvold M Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024 [TBL] [Abstract][Full Text] [Related]
8. Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: cross-sectional findings from the neuropsychological TEAM-side study. Schilder CM; Eggens PC; Seynaeve C; Linn SC; Boogerd W; Gundy CM; Beex LV; Van Dam FS; Schagen SB Acta Oncol; 2009; 48(1):76-85. PubMed ID: 18777410 [TBL] [Abstract][Full Text] [Related]
9. Cognitive problems after chemotherapy for breast cancer. Harv Womens Health Watch; 2002 Oct; 10(2):5-6. PubMed ID: 12393318 [No Abstract] [Full Text] [Related]
10. Cognitive impairment associated with adjuvant therapy in breast cancer. Bender CM; Sereika SM; Berga SL; Vogel VG; Brufsky AM; Paraska KK; Ryan CM Psychooncology; 2006 May; 15(5):422-30. PubMed ID: 16097037 [TBL] [Abstract][Full Text] [Related]
11. Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma. Donovan KA; Small BJ; Andrykowski MA; Schmitt FA; Munster P; Jacobsen PB Cancer; 2005 Dec; 104(11):2499-507. PubMed ID: 16247788 [TBL] [Abstract][Full Text] [Related]
12. Self-reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side-study. Schilder CM; Seynaeve C; Linn SC; Boogerd W; Beex LV; Gundy CM; Nortier JW; van de Velde CJ; van Dam FS; Schagen SB Psychooncology; 2012 May; 21(5):479-87. PubMed ID: 21351188 [TBL] [Abstract][Full Text] [Related]
13. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy. Koppelmans V; Breteler MM; Boogerd W; Seynaeve C; Gundy C; Schagen SB J Clin Oncol; 2012 Apr; 30(10):1080-6. PubMed ID: 22370315 [TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy. Jim HS; Phillips KM; Chait S; Faul LA; Popa MA; Lee YH; Hussin MG; Jacobsen PB; Small BJ J Clin Oncol; 2012 Oct; 30(29):3578-87. PubMed ID: 22927526 [TBL] [Abstract][Full Text] [Related]
15. Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study. Jenkins V; Shilling V; Fallowfield L; Howell A; Hutton S Psychooncology; 2004 Jan; 13(1):61-6. PubMed ID: 14745746 [TBL] [Abstract][Full Text] [Related]
16. Effects of high-dose and conventional-dose adjuvant chemotherapy on long-term cognitive sequelae in patients with breast cancer: an electrophysiologic study. Kreukels BP; Schagen SB; Ridderinkhof KR; Boogerd W; Hamburger HL; Muller MJ; van Dam FS Clin Breast Cancer; 2006 Apr; 7(1):67-78. PubMed ID: 16764746 [TBL] [Abstract][Full Text] [Related]
17. 'Chemobrain' in breast carcinoma?: a prologue. Wefel JS; Lenzi R; Theriault R; Buzdar AU; Cruickshank S; Meyers CA Cancer; 2004 Aug; 101(3):466-75. PubMed ID: 15274059 [TBL] [Abstract][Full Text] [Related]
18. The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature. Falleti MG; Sanfilippo A; Maruff P; Weih L; Phillips KA Brain Cogn; 2005 Oct; 59(1):60-70. PubMed ID: 15975700 [TBL] [Abstract][Full Text] [Related]
19. Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. Tchen N; Juffs HG; Downie FP; Yi QL; Hu H; Chemerynsky I; Clemons M; Crump M; Goss PE; Warr D; Tweedale ME; Tannock IF J Clin Oncol; 2003 Nov; 21(22):4175-83. PubMed ID: 14615445 [TBL] [Abstract][Full Text] [Related]
20. Neurotoxic Effects of Anthracycline- vs Nonanthracycline-Based Chemotherapy on Cognition in Breast Cancer Survivors. Kesler SR; Blayney DW JAMA Oncol; 2016 Feb; 2(2):185-92. PubMed ID: 26633037 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]